Lu Han

2.3k total citations · 1 hit paper
59 papers, 1.4k citations indexed

About

Lu Han is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Lu Han has authored 59 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 21 papers in Immunology and 17 papers in Molecular Biology. Recurrent topics in Lu Han's work include CAR-T cell therapy research (21 papers), Cancer Immunotherapy and Biomarkers (16 papers) and Immunotherapy and Immune Responses (11 papers). Lu Han is often cited by papers focused on CAR-T cell therapy research (21 papers), Cancer Immunotherapy and Biomarkers (16 papers) and Immunotherapy and Immune Responses (11 papers). Lu Han collaborates with scholars based in China, United States and Italy. Lu Han's co-authors include Yangyang Kan, Jie Tian, Yahong Luo, Wenyan Jiang, Di Dong, Quanli Gao, Jian Wang, Jishuai Zhang, Xu Shu and Jing Cui and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Lu Han

59 papers receiving 1.4k citations

Hit Papers

CRISPR/Cas9-Engineered Universal CD19/CD22 Dual-Targeted ... 2021 2026 2022 2024 2021 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. CRISPR/Cas9-Engineered Universal CD19/CD22 Dual-Targeted CAR-T Cell Therapy for Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia
    2021 202 citations Yongxian Hu, Yali Zhou et al. Clinical Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lu Han China 19 684 421 406 283 181 59 1.4k
Jennifer Watkins United Kingdom 20 450 0.7× 300 0.7× 434 1.1× 163 0.6× 135 0.7× 58 1.5k
Ling Fu China 19 598 0.9× 330 0.8× 559 1.4× 170 0.6× 64 0.4× 59 1.5k
Tomoharu Sugie Japan 25 656 1.0× 674 1.6× 278 0.7× 264 0.9× 250 1.4× 87 1.9k
Tessa Kerre Belgium 26 769 1.1× 940 2.2× 670 1.7× 73 0.3× 68 0.4× 112 2.1k
Alfonso R. Sánchez-Paulete Spain 21 1.3k 1.9× 1.5k 3.5× 402 1.0× 112 0.4× 78 0.4× 27 2.1k
Stephen J. Blake Australia 20 1.3k 1.9× 1.1k 2.6× 513 1.3× 78 0.3× 185 1.0× 36 2.3k
Amy Ly United States 16 231 0.3× 225 0.5× 291 0.7× 149 0.5× 69 0.4× 63 1.1k
Robert K. Bright United States 22 477 0.7× 497 1.2× 670 1.7× 130 0.5× 79 0.4× 60 1.5k
Todd Meyer United States 16 252 0.4× 277 0.7× 308 0.8× 151 0.5× 115 0.6× 45 1.1k

Countries citing papers authored by Lu Han

Since Specialization
Citations

This map shows the geographic impact of Lu Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu Han more than expected).

Fields of papers citing papers by Lu Han

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lu Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu Han. The network helps show where Lu Han may publish in the future.

Co-authorship network of co-authors of Lu Han

This figure shows the co-authorship network connecting the top 25 collaborators of Lu Han. A scholar is included among the top collaborators of Lu Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lu Han. Lu Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Xiangmin, Qing Zhang, Hongyuan Zhou, et al.. (2024). Impact of tocilizumab on anti‐CD19 chimeric antigen receptor T‐cell therapy in B‐cell acute lymphoblastic leukemia. Cancer. 130(15). 2660–2669. 3 indexed citations
2.
Han, Lu, et al.. (2024). Application of a recombinant novel trypsin from Trichinella spiralis for serodiagnosis of trichinellosis. Parasites & Vectors. 17(1). 9–9. 12 indexed citations
3.
Zhang, Ru, Xin Zhuo Zhang, Lu Han, et al.. (2023). The protective immunity induced by Trichinella spiralis galectin against larval challenge and the potential of galactomannan as a novel adjuvant. Research in Veterinary Science. 165. 105075–105075. 6 indexed citations
4.
Song, Fei, et al.. (2023). PANoptosis-based molecular subtyping and HPAN-index predicts therapeutic response and survival in hepatocellular carcinoma. Frontiers in Immunology. 14. 1197152–1197152. 38 indexed citations
5.
Fu, Qiang, Lingdi Zhao, Xiaomin Fu, et al.. (2022). Efficacy and Safety of Apatinib in Patients with Recurrent or Refractory Melanoma. The Oncologist. 27(6). e463–e470. 9 indexed citations
6.
Guo, Kai, Zhiqiang Ma, Yujiao Zhang, et al.. (2022). HDAC7 promotes NSCLC proliferation and metastasis via stabilization by deubiquitinase USP10 and activation of β-catenin-FGF18 pathway. Journal of Experimental & Clinical Cancer Research. 41(1). 91–91. 40 indexed citations
7.
Zeng, Jie, Ru Zhang, Lu Han, et al.. (2022). Characterization of a novel aminopeptidase P from Trichinella spiralis and its participation in the intrusion of intestinal epithelial cells. Experimental Parasitology. 242. 108376–108376. 5 indexed citations
8.
9.
Peng, Ling, Bicheng Zhang, Brian G. Till, et al.. (2022). Combination of Low-Dose Gemcitabine and PD-1 Inhibitors for Treatment in Patients With Advanced Malignancies. Frontiers in Immunology. 13. 882172–882172. 4 indexed citations
10.
Han, Lu, Xu Shu, & Jian Wang. (2022). Helicobacter pylori-Mediated Oxidative Stress and Gastric Diseases: A Review. Frontiers in Microbiology. 13. 811258–811258. 50 indexed citations
11.
12.
Zheng, Cuixia, Xinxin Liu, Lei Zhang, et al.. (2022). Hyperthermia based individual in situ recombinant vaccine enhances lymph nodes drainage for de novo antitumor immunity. Acta Pharmaceutica Sinica B. 12(8). 3398–3409. 15 indexed citations
13.
Hu, Yongxian, Yali Zhou, Mingming Zhang, et al.. (2021). CRISPR/Cas9-Engineered Universal CD19/CD22 Dual-Targeted CAR-T Cell Therapy for Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia. Clinical Cancer Research. 27(10). 2764–2772. 202 indexed citations breakdown →
14.
Han, Lu, Jishuai Zhang, Jian Zhou, et al.. (2021). Single VHH-directed BCMA CAR-T cells cause remission of relapsed/refractory multiple myeloma. Leukemia. 35(10). 3002–3006. 33 indexed citations
15.
Han, Lu, Shikai Wu, Xiujuan Qu, et al.. (2021). Real-world outcomes of regorafenib combined with immune checkpoint inhibitors in patients with advanced or metastatic microsatellite stable colorectal cancer: A multicenter study. Cancer Immunology Immunotherapy. 71(6). 1443–1451. 20 indexed citations
16.
17.
Han, Lu, Jian Zhou, Linlin Li, et al.. (2021). Culturing adequate CAR-T cells from less peripheral blood to treat B-cell malignancies. Cancer Biology and Medicine. 18(-). 0–0. 5 indexed citations
18.
Han, Lu, et al.. (2020). Global genetic diversity of Spirometra tapeworms.. Tropical biomedicine. 37(1). 237–250. 5 indexed citations
19.
Xue, Feng, Lu Han, Sijia Ma, et al.. (2020). Microbes in Tumoral In Situ Tissues and in Tumorigenesis. Frontiers in Cellular and Infection Microbiology. 10. 572570–572570. 3 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jennifer Watkins Breakdown of academic impact, for papers by Ling Fu Breakdown of academic impact, for papers by Tomoharu Sugie Breakdown of academic impact, for papers by Tessa Kerre Breakdown of academic impact, for papers by Alfonso R. Sánchez-Paulete Breakdown of academic impact, for papers by Stephen J. Blake Breakdown of academic impact, for papers by Amy Ly Breakdown of academic impact, for papers by Robert K. Bright Breakdown of academic impact, for papers by Todd Meyer
Rankless by CCL
2026